BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11920339)

  • 21. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
    Miyakoshi M; Kamoi K; Uchida S; Sasaki S
    Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus.
    Tsukaguchi H; Matsubara H; Aritaki S; Kimura T; Abe S; Inada M
    Biochem Biophys Res Commun; 1993 Dec; 197(2):1000-10. PubMed ID: 8267567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathological aspects of water transport in the collecting ducts].
    Bichet DG
    Nephrologie; 1996; 17(7):417-22. PubMed ID: 9019668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
    Faerch M; Christensen JH; Rittig S; Johansson JO; Gregersen N; de Zegher F; Corydon TJ
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
    Böselt I; Tramma D; Kalamitsou S; Niemeyer T; Nykänen P; Gräf KJ; Krude H; Marenzi KS; Di Candia S; Schöneberg T; Schulz A
    Nephrol Dial Transplant; 2012 Apr; 27(4):1521-8. PubMed ID: 21917732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.
    de Mattia F; Savelkoul PJ; Bichet DG; Kamsteeg EJ; Konings IB; Marr N; Arthus MF; Lonergan M; van Os CH; van der Sluijs P; Robertson G; Deen PM
    Hum Mol Genet; 2004 Dec; 13(24):3045-56. PubMed ID: 15509592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
    Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
    Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
    Ding C; Beetz R; Rittner G; Bartsch O
    Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin receptor mutations in nephrogenic diabetes insipidus.
    Bichet DG
    Semin Nephrol; 2008 May; 28(3):245-51. PubMed ID: 18519085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.
    Bockenhauer D; Carpentier E; Rochdi D; van't Hoff W; Breton B; Bernier V; Bouvier M; Bichet DG
    Nephron Physiol; 2010; 114(1):p1-10. PubMed ID: 19816050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family.
    Yamashita S; Hata A; Usui T; Oda H; Hijikata A; Shirai T; Kaneko N; Hata D
    J Pediatr Endocrinol Metab; 2016 May; 29(5):591-6. PubMed ID: 26974133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biology of hereditary diabetes insipidus.
    Fujiwara TM; Bichet DG
    J Am Soc Nephrol; 2005 Oct; 16(10):2836-46. PubMed ID: 16093448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Mutation in the
    Çelebi Tayfur A; Karaduman T; Özcan Türkmen M; Şahin D; Çaltık Yılmaz A; Büyükkaragöz B; Buluş AD; Mergen H
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):350-356. PubMed ID: 29991464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
    García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G;
    Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.
    Ala Y; Morin D; Mouillac B; Sabatier N; Vargas R; Cotte N; Déchaux M; Antignac C; Arthus MF; Lonergan M; Turner MS; Balestre MN; Alonso G; Hibert M; Barberis C; Hendy GN; Bichet DG; Jard S
    J Am Soc Nephrol; 1998 Oct; 9(10):1861-72. PubMed ID: 9773787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compound deletion of the rhoGAP C1 and V2 vasopressin receptor genes in a patient with nephrogenic diabetes insipidus.
    Schöneberg T; Pasel K; von Baehr V; Schulz A; Volk HD; Gudermann T; Filler G
    Hum Mutat; 1999; 14(2):163-74. PubMed ID: 10425039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.
    van Lieburg AF; Verdijk MA; Schoute F; Ligtenberg MJ; van Oost BA; Waldhauser F; Dobner M; Monnens LA; Knoers NV
    Hum Genet; 1995 Jul; 96(1):70-8. PubMed ID: 7607658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.